AP2007004219A0 - Anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-YL-amino)-1H-pyrazolo[4,3-D] pyrimidine-3-carbonyl]methanesulfonamide - Google Patents

Anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-YL-amino)-1H-pyrazolo[4,3-D] pyrimidine-3-carbonyl]methanesulfonamide

Info

Publication number
AP2007004219A0
AP2007004219A0 AP2007004219A AP2007004219A AP2007004219A0 AP 2007004219 A0 AP2007004219 A0 AP 2007004219A0 AP 2007004219 A AP2007004219 A AP 2007004219A AP 2007004219 A AP2007004219 A AP 2007004219A AP 2007004219 A0 AP2007004219 A0 AP 2007004219A0
Authority
AP
ARIPO
Prior art keywords
methanesulfonamide
methylpyridin
pyrazolo
ethoxyethyl
methylamino
Prior art date
Application number
AP2007004219A
Other languages
English (en)
Inventor
David Andrew Entwistle
Peter Vallance Marshall
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority claimed from PCT/IB2006/001233 external-priority patent/WO2006120552A2/en
Publication of AP2007004219A0 publication Critical patent/AP2007004219A0/xx

Links

AP2007004219A 2005-05-12 2006-05-03 Anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-YL-amino)-1H-pyrazolo[4,3-D] pyrimidine-3-carbonyl]methanesulfonamide AP2007004219A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68044505P 2005-05-12 2005-05-12
PCT/IB2006/001233 WO2006120552A2 (en) 2005-05-12 2006-05-03 ANHYDROUS CRYSTALLINE FORMS OF N-[1-(2-ETHOXYETHYL)-5-(N-ETHYL-N-METHYLAMINO)-7-(4-METHYLPYRIDIN-2-yl-AMINO)-1H-PYRAZOLO[4,3-d]PYRIMIDINE-3-CARBONYL]METHANESULFONAMIDE

Publications (1)

Publication Number Publication Date
AP2007004219A0 true AP2007004219A0 (en) 2007-10-31

Family

ID=39156659

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007004219A AP2007004219A0 (en) 2005-05-12 2006-05-03 Anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-YL-amino)-1H-pyrazolo[4,3-D] pyrimidine-3-carbonyl]methanesulfonamide

Country Status (5)

Country Link
CN (1) CN101175758B (es)
AP (1) AP2007004219A0 (es)
ES (1) ES2357120T3 (es)
SI (1) SI1881985T1 (es)
ZA (1) ZA200708733B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2015115005A (ru) * 2012-10-23 2016-12-20 Пфайзер Инк. Применение тетразамещенных производных [4,3-d] пиримидина для лечения диабетической нефропатии
CN112903589A (zh) * 2021-04-13 2021-06-04 塔里木大学 一种基于拉曼光谱的苹果糖分检测设备

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA13050A (en) * 2003-04-29 2006-11-10 Pfizer Ltd 5,7-diaminopyrazolo [4,3-D] pyrimidines useful in the treatment of hypertension.

Also Published As

Publication number Publication date
ES2357120T3 (es) 2011-04-18
CN101175758A (zh) 2008-05-07
ZA200708733B (en) 2009-07-29
SI1881985T1 (sl) 2011-03-31
CN101175758B (zh) 2011-06-22

Similar Documents

Publication Publication Date Title
HRP20181912T1 (hr) Derivati pirolo[2,3-d]pirimidina kao inhibitori janus kinaze
HK1143154A1 (en) Pyrrolo [2, 3 -d] pyrimidin derivatives as protein kinase b inhibitors b[23-d]
HK1160116A1 (en) Pyrrolo[2,3-d]pyrimidine compounds [23-d]
HRP20180578T1 (hr) Pirolo[2,3-b]piridin-4-il-amini i pirolo[2m3-b]pirimidin-4-il-amini kao inhibitori janus kinaze
WO2006120552A3 (en) ANHYDROUS CRYSTALLINE FORMS OF N-[1-(2-ETHOXYETHYL)-5-(N-ETHYL-N-METHYLAMINO)-7-(4-METHYLPYRIDIN-2-yl-AMINO)-1H-PYRAZOLO[4,3-d]PYRIMIDINE-3-CARBONYL]METHANESULFONAMIDE
IL195238A0 (en) Pyrazolo [1,5-a]pyrimidines as cdk inhibitors
ZA200802998B (en) Use of pyrazolo [1,5-a] pyrimidine derivatives for inhibiting protein kinases methods for inhibiting protein kinases
SI1893612T1 (sl) Pirolo b piridin derivati kot protein kinazni inhibitorji
IL212341A0 (en) Substituted pyrazolo [1,5-a] pyrimidine compounds as trk kinase inhibitors
IL182099A0 (en) Piperidinylamino-thieno[2,3-d] pyrimidine compounds
HK1198652A1 (zh) 激酶抑制劑 -吡咯 嘧啶- -基 -吡唑- -基 -環戊基丙腈的結晶鹽
SI1904494T1 (sl) Imidazo(1,2-a)piridin spojine kot inhibitorji vegf-r2
TWI319402B (en) Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis
IL175813A0 (en) PYRIDO [2,3-d] PYRIMIDINE-2,4-DIAMINES AS PDE 2 INHIBITORS
AP2010005346A0 (en) 3H-[1,2,3]triazolo[4,5-D]pyrimidine compounds, their use as mTOR kinase and P13 kinase inhibitors, and their synthesis.
ZA200803173B (en) Pyrazolo [4,3-d] Pyrimidin-5-yl) Derivative used as PDE5 Inhibitors
IL174845A0 (en) Benzazepine derivatives as mao-b inhibitors
AP2007004219A0 (en) Anhydrous crystalline forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-YL-amino)-1H-pyrazolo[4,3-D] pyrimidine-3-carbonyl]methanesulfonamide